Is Anlotinib Hydrochloride Capsules a chemotherapy drug?
May 04, 2023
Source: Cainiu Health
Dr. Qi Zhirong
Introduction
Anlotinib hydrochloride capsules are not a chemotherapeutic agent, but belong to targeted therapy drugs. Anlotinib hydrochloride capsules are small-molecule targeted agents indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer who have progressed or relapsed after at least two prior systemic chemotherapy regimens. This drug can also be used in patients with iodine-refractory, locally advanced or metastatic differentiated thyroid cancer who are not candidates for surgery.
Anlotinib hydrochloride capsules are not a chemotherapy drug; they belong to the category of targeted therapy medications. The detailed explanation is as follows:
Anlotinib hydrochloride capsules are a novel anti-lung cancer agent classified as a small-molecule targeted therapeutic drug. The active ingredient is anlotinib hydrochloride. This medication is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have shown disease progression or recurrence after at least two prior systemic chemotherapy regimens. It can also be used to treat patients with iodine-refractory, locally advanced or metastatic differentiated thyroid cancer who are not candidates for surgery. Additionally, the drug has demonstrated certain effects in inducing cancer cell apoptosis and reducing cancer cell activity.
Anlotinib hydrochloride capsules may cause adverse reactions such as proteinuria and hypertension. Therefore, the medication should be taken under the guidance of a physician to minimize potential adverse effects on the body.
